Companies in #Small Molecule Therapeutics

Remix Therapeutics is a clinical-stage biotechnology company developing small-molecule RNA-targeted therapeutics that modulate RNA processing. The company announced a reverse merger with Passage Bio in 2026 to take Passage's Nasdaq listing while advancing its lead mRNA degrader program.